Concepedia

Lenalidomide enhances the function of dendritic cells generated from patients with multiple myeloma

Manh-Cuong Vo, Truc Anh-NguyenThi, Hyunju Lee, Thanh-Nhan Nguyen-Pham, Thangaraj Jaya Lakshmi, Sung‐Hoon Jung, Hyeoung‐Joon Kim, Je‐Jung Lee

Experimental Hematology · 2016 · 35 citations · 27 references

DOIFull text

Open access

Concepts

References

27

Lenalidomide plus Dexamethasone for Relapsed or Refractory Multiple Myeloma

Meletios Α. Dimopoulos, Andrew Spencer, Michael Attal et al. · New England Journal of Medicine · 2007 · 1.5K citations

, , +14

Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma

Sagar Lonial, Meletios Α. Dimopoulos, Antonio Palumbo et al. · New England Journal of Medicine · 2015 · 1.3K citations · Full text

, , +16

Lenalidomide plus Dexamethasone for Relapsed Multiple Myeloma in North America

Donna M. Weber, Christine Chen, Rubén Niesvizky et al. · New England Journal of Medicine · 2007 · 1.2K citations · Full text

, , +14

Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity

José Mayordomo, Tatiana Zorina, Walter J. Storkus et al. · Nature Medicine · 1995 · 1.1K citations

, , +15

Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma

Faith E. Davies, Noopur Raje, Teru Hideshima et al. · Blood · 2001 · 905 citations

, , +12